Stock Events

Stock Events

Madrigal Pharmaceuticals (MDGL) Q2 2026 Earnings

6MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-5.08

-3.69

-2.29

-0.9

Details

Expected EPS

-4.229637

Actual EPS

-3.25

Surprise EPS

0.98

Surprise Percent

+23.16%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -3.25 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.